Sartar Therapeutics develops treatment for soft tissue sarcomas. The focus of cancer therapy is moving towards personalised medicine. There is a clear unmet need to find new therapies for the broad and heterogeneous group of soft tissue sarcomas. We are committed to delivering innovative, therapeutic options for the patients who currently have no specific therapies and for those who have run out of all currently available options.
| Website | https://sartartherapeutics.com/ |
| Revenue | $2 million |
| Employees | 8 (6 on RocketReach) |
| Founded | 2016 |
| Address | Haartmaninkatu 4, Bldg 14, Helsinki, Uusimaa 00290, FI |
| Phone | +358 9 47171913 |
| Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Science and Engineering, Healthcare |
| Keywords | Sarcoma Research, Personalized Cancer Therapy, Targeted Cancer Therapy, Personalized Oncology, Cancer Drug Development, Novel Cancer Treatments, New Cancer Drugs, Cancer Treatment Innovation, Oncology Therapeutics, Innovative Cancer Therapies, Advanced Cancer Therapies, Unmet Medical Needs, Cancer Clinical Trials |
| Competitors | Novartis, Pfizer, AbbVie, Roche, Gilead Sciences, Amgen, Bristol Myers Squibb, Merck & Co., Inc., AstraZeneca, Johnson & Johnson +41 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Sartar Therapeutics employee's phone or email?
Sartar Therapeutics Questions
The Sartar Therapeutics annual revenue was $2 million in 2026.
Mikael Maksimow is the CEO of Sartar Therapeutics.
6 people are employed at Sartar Therapeutics.
Sartar Therapeutics is based in Helsinki, Uusimaa.
The NAICS codes for Sartar Therapeutics are [541713, 5417, 54171, 541, 54].
The SIC codes for Sartar Therapeutics are [87, 873].
Top Sartar Therapeutics Employees
Related Companies
